Ifosfamide (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Ifosfamide drug offered from Pfizer Laboratories Div Pfizer Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
NON-PROPRIETARY NAME: | Ifosfamide |
SUBSTANCE NAME: | IFOSFAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-11-27 |
END MARKETING DATE: | 0000-00-00 |
Ifosfamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Ifosfamide from Pfizer Laboratories Div Pfizer Inc. |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2012-11-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-4495_4bb31494-d895-4d80-a72a-c80aff94f402 |
PRODUCT NDC: | 0069-4495 |
APPLICATION NUMBER: | ANDA201689 |
Other IFOSFAMIDE Pharmaceutical Manufacturers / Labelers: